Surgical treatment is the gold standard treatment of functional tricuspid regurgitation (FTR) but this carries high risks of morbidity and mortality. Percutaneous procedures are an attractive alternative to surgery for selected patients deemed to be high-risk surgical candidates. A number of tricuspid transcatheter devices have been developed to treat FTR, but at present, evidence of their efficacy and safety is scarce. Preliminary data have shown promising results, but ongoing and future studies will provide a clearer picture of the benefits of these new techniques.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808466PMC
http://dx.doi.org/10.15420/icr.2017:3:2DOI Listing

Publication Analysis

Top Keywords

tricuspid regurgitation
8
management tricuspid
4
regurgitation role
4
role transcatheter
4
transcatheter therapies
4
therapies surgical
4
surgical treatment
4
treatment gold
4
gold standard
4
standard treatment
4

Similar Publications

Background: Intermediate-high risk pulmonary embolism (PE) carries a significant risk of hemodynamic deterioration or death. Treatment should balance efficacy in reducing clot burden with the risk of complications, particularly bleeding. Previous studies on high-dose, short-term thrombolysis with alteplase (rtPA) showed a reduced risk of hemodynamic deterioration but no change in mortality and increased bleeding complications.

View Article and Find Full Text PDF

Recently published data suggested significantly lower pacing-induced cardiomyopathy (PICM) incidence with conduction system pacing (CSP). Because most data evaluated only the impact on the left ventricle, this study aimed to assess changes in echocardiographic parameters of morphology and function for all heart chambers in patients with baseline preserved and mid-range LVEF over a medium-term follow-up period after CSP. A total of 128 consecutive patients with LVEF > 40% and successful CSP for bradyarrhythmic indication were prospectively enrolled.

View Article and Find Full Text PDF

Noncardiogenic pulmonary edema after cardiac surgery is a rare but severe complication. The etiology remains poorly understood; however, the issue may arise from multiple sources. Possible causes include a significant inflammatory response or an autoimmune process.

View Article and Find Full Text PDF
Article Synopsis
  • The aim of the study was to create a reproducible animal model of tricuspid regurgitation (TR) using a self-expanding nickel-titanium stent.
  • The experiment involved 10 pigs, 7 in the experimental group undergoing TR induction through stent implantation, while 3 served as controls without the stent.
  • Results showed significant changes in cardiac structure and function in the experimental group, indicating successful model establishment with no fatalities, making this approach effective for further research on right ventricular issues.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!